Skip to main content
. 2022 Dec 30;56:101810. doi: 10.1016/j.eclinm.2022.101810

Fig. 1.

Fig. 1

Participant selection for the primary incidence analysis from five InCHEHC countries. InCHEHC: International Collaboration on Hepatitis C Elimination in HIV Cohorts; PLHIV: people living with HIV; HCV: hepatitis C virus; ACCESS: Australian Collaboration for Coordinated Enhanced Sentinel Surveillance; Ab: antibody; HCVsc: HCV seroconversions. We excluded ACCESS participants that only had data recorded prior to 2009 as data collection started from that year onwards (n = 244).